The University of Chicago Header Logo

Connection

J. Thistlethwaite to Antibodies, Monoclonal

This is a "connection" page, showing publications J. Thistlethwaite has written about Antibodies, Monoclonal.
Connection Strength

1.132
  1. Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group. Transplantation. 2000 Sep 15; 70(5):784-90.
    View in: PubMed
    Score: 0.121
  2. Treatment with either anti-CD4 or anti-CD8 monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation. 1997 Oct 15; 64(7):959-65.
    View in: PubMed
    Score: 0.099
  3. Immunomodulation of human islets results in prolonged in vivo islet graft survival. Transplant Proc. 1995 Feb; 27(1):611-2.
    View in: PubMed
    Score: 0.082
  4. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model. Transplant Proc. 1994 Apr; 26(2):771-3.
    View in: PubMed
    Score: 0.078
  5. Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients. Am J Kidney Dis. 1989 Nov; 14(5 Suppl 2):28-34.
    View in: PubMed
    Score: 0.057
  6. Complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988 Feb; 11(2):112-9.
    View in: PubMed
    Score: 0.051
  7. Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
    View in: PubMed
    Score: 0.051
  8. The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4.
    View in: PubMed
    Score: 0.047
  9. OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
    View in: PubMed
    Score: 0.047
  10. Ex vivo perfusion of the intact rat pancreas with anti-class II monoclonal antibody: labeling of dendritic cells. Transplant Proc. 1987 Feb; 19(1 Pt 1):620-3.
    View in: PubMed
    Score: 0.047
  11. Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation. 1984 Dec; 38(6):695-701.
    View in: PubMed
    Score: 0.041
  12. Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation. 2000 Mar 15; 69(5):904-9.
    View in: PubMed
    Score: 0.029
  13. Differential effect of an anti-CD8 monoclonal antibody on rejection of murine intestine and cardiac allografts. Transplant Proc. 1999 Feb-Mar; 31(1-2):1239-41.
    View in: PubMed
    Score: 0.027
  14. Inhibition of intestinal allograft rejection by an anti-CD8 monoclonal antibody is not mediated by depletion alone. Transplant Proc. 1998 Jun; 30(4):1069-70.
    View in: PubMed
    Score: 0.026
  15. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation. 1995 Nov 27; 60(10):1171-8.
    View in: PubMed
    Score: 0.022
  16. Intrathymic xenogeneic pancreatic islet transplantation--induction of donor-specific unresponsiveness by MHC class II peptides. Transplant Proc. 1995 Feb; 27(1):176-7.
    View in: PubMed
    Score: 0.021
  17. Inhibition of T-cell activation by an anti-human class I MHC reactive monoclonal antibody occurs at a point distal to TCR-CD3 mediated signal transduction. Transplant Proc. 1995 Feb; 27(1):395-7.
    View in: PubMed
    Score: 0.021
  18. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies. Transplantation. 1994 Sep 27; 58(6):681-9.
    View in: PubMed
    Score: 0.020
  19. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol. 1994 Sep 15; 153(6):2738-49.
    View in: PubMed
    Score: 0.020
  20. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules. J Immunol. 1994 Aug 01; 153(3):1054-67.
    View in: PubMed
    Score: 0.020
  21. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. Transplant Proc. 1994 Jun; 26(3):1120.
    View in: PubMed
    Score: 0.020
  22. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation. Transplant Proc. 1994 Jun; 26(3):1201-2.
    View in: PubMed
    Score: 0.020
  23. Anti-CD3 monoclonal antibody therapy. An approach toward optimization by in vitro analysis of new anti-CD3 antibodies. Transplantation. 1991 Aug; 52(2):361-8.
    View in: PubMed
    Score: 0.016
  24. OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release. Transplantation. 1991 Aug; 52(2):354-60.
    View in: PubMed
    Score: 0.016
  25. OKT3 therapy for hepatic allograft rejection. Differential response in adults and children. Transplantation. 1991 Jun; 51(6):1207-12.
    View in: PubMed
    Score: 0.016
  26. T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Transplant Proc. 1991 Feb; 23(1 Pt 1):81-2.
    View in: PubMed
    Score: 0.016
  27. T lymphocyte activation following OKT3 treatment. Curr Surg. 1990 Nov-Dec; 47(6):458-9.
    View in: PubMed
    Score: 0.015
  28. Activation of human T cells in vivo following treatment of transplant recipients with OKT3. Transplantation. 1990 Oct; 50(4):608-12.
    View in: PubMed
    Score: 0.015
  29. OKT3 therapy for hepatic allograft rejection: comparison of results in adults and children. Transplant Proc. 1990 Aug; 22(4):1765-6.
    View in: PubMed
    Score: 0.015
  30. Pancreas-graft immunogenicity and pretreatment with anti-class II monoclonal antibodies. Diabetes. 1989 Jan; 38 Suppl 1:104-8.
    View in: PubMed
    Score: 0.013
  31. Reexposure to OKT3 in renal allograft recipients. Transplantation. 1988 Feb; 45(2):349-53.
    View in: PubMed
    Score: 0.013
  32. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation. 2001 May 15; 71(9):1351-4.
    View in: PubMed
    Score: 0.008
  33. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation. 1999 Jan 15; 67(1):131-7.
    View in: PubMed
    Score: 0.007
  34. Role of CD8+ and CD4+ T cells in the rejection of murine intestinal allografts. Transplant Proc. 1998 Sep; 30(6):2592-3.
    View in: PubMed
    Score: 0.007
  35. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 07; 257(5071):789-92.
    View in: PubMed
    Score: 0.004
  36. Immunohistochemical detection of antibody in tissue sections of non-perfused and ex vivo-perfused organs using a tetrazolium alkaline phosphatase substrate. Histochemistry. 1988; 89(5):443-6.
    View in: PubMed
    Score: 0.003
  37. Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Am Surg. 1987 Jul; 53(7):407-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.